Although jine-needle aspiration biopsy ofsalivary gland masses has been reported in the otolaryngology literature, the use of sonography to guide the biopsy of nonpalpable masses and masses seen on other crosssectional imaging studieshas not been described. Our goal was to evaluate sonographically guided biopsy of masses and lymph nodes related to the salivary glands.
Introduction
The performance offine-needle aspiration biopsy (FNAB) ofpalpable neck masses, including salivary gland tumors, without imaging guidance has been .described in the literature."? As technology continues to imprave, sonographic guidance is becoming common for FNAB of small, nonpalpable lesions , particularly in metastases from head and neck malignancies OI' thyro id nodules. P:"
When masses in the submandibular region are palpated, it is not always possible to differentiate a mass related to the salivary gland from aregionallymph node. Sonography can usually make this distinction, although this can be difficult in the jugulodigastric region." At our institution, sonographic guidance has also been used to biopsy masse s of the salivary gland s, including the parotid gland. Neoplasms pose a particular challenge to the cytop athologist because of the wide spectrum of tumors, including (in order of increasing potential for malignancy) pleomorphic adenomas, adenolymphomas (Wa rthin' s tumor), acinic eeli carcinomas, adenoid-cystic carcinomas, and mucoepidermoid carcinomas ." :"
We rev iewed our experience with sonographically guided FNAB of masses related to the salivary glands. We hypothesized that a definitive tissue diagnosis, benign OI' FELD. NAZAR IAN. NEEDLEMAN. LEV-TOAF F. SEGA L, RAO, 81880 . LOW RY - Figure 1 . Patient 6 is a 54 -year-old woman who presented with pain. A long itud inal sonogram of her parotid gland demonstrates a homog eneous hypoechoic mass measuring 10 x 5 x 9 mm. Fine-need le aspiration biopsy showe d scanty cellularity, which is compatible with adenoma, but excisional biopsy revealed an acinic eeli carcinoma.
maligna nt, can be made based on cytopathology from sonographically guided FNAB . To our knowledge, there has been no other reported series dealing specifically with sonographically guided biopsy of salivary gla nd masses.
Materials and methods
"A computer search spa nning an l l-year period from March 1987 to March 1998 revea led that 18 patients had been referred to our inst itution for a sonographically guided biopsy of a parotid or submandib ular mass. The indicat ions for biopsy included non palpable masses seen on ear lier cross-sectional imagi ng and palpab le masses in which imagi ng localization was felt to be cri tica l for biopsy. All iesions had been seen on previous magnetic reso nanee imagin g (MRI), com puted tomograph y (CT), or sonography . The ten men and eig ht wo men ranged in age from 32 to 8 1 years (mean: 60). Parotid and subma ndibular masses were identified as foca l masses surro unded by more echoge nic salivary gland tissue (fig ures I, 2). Lymp h nodes were identified by their loca tion around the salivary gland and by their shape, either ellipsoid or rounded, with or wit hout a central echogenic hilus (figures 3, 4) .
Based on their sonographic appearance, we identified II intraparotid masses, five perisubmandibular Iymph nodes, and two periparotid Iymph nodes. The masses and Iymph nodes ranged in size from 5 x 4 x 3 mm to 38 x 20 x 25 mm. Eleve n were palpable . The masses were biopsied under continuous sonographic guidance with a 25-, 22-, or20-gauge needle; two parotid masses were also bio psied with a 20-ga uge automa ted core device (Tem no, Bauer Medica l; Clearwater, Fia.). So nographica lly guided biopsies were performed with the free-hand techn ique under steriie co nditio ns, with passes directed to the solid port ion 908 of the mass during rea l-time monitoring. Linear highfrequency probes with multifrequency capabilities (l0-5 MHz or 7-4 MHz) were used (Advanced Technology Laboratories; Bot hel , Was h.). Either a cytotechnologist or a cytopathology fellow was present at the time of biopsy to stain the aspirated material and to determine if there was adequate cellu larityi n the specimen.
The smea rs of the aspirated material were stai ned by rapid Papanicolaou technique, and the remaining material was submitted for eeli block. For eac h mass, one to six biopsy passes (mean : 2.8) were necessary. Excisional surgery was performed on eigh t patients follow ing the FNA B, and cytology in these cases was co mpare d with surgica l pathology; one patient refused surgery. For the remai ning nine patient s, cli nica l or imagi ng followup was obtained.
Results
Six patie nts (cases 1-6) had adenomatous paro tid masses, two (cases 7, 8) had nonadenomatous parotid masses, and ten (cases 9-18) had intra-or perisaliva ry gla nd Iymph nodes (table) . Overall, cyto logy was defini tive for a specific diagnosis in 13 of the 18 patients (72 %): three cases of reac tive Iymph node, two cases eac h of Iymph node metas tasis and parotid Warthin's tumor, and in one case each of parotid pleomorphic adenoma, paro tid adenoid-cystic carci noma, parotid schwannorna-neurofibroma, parotid metastasis, parotid Iymph oma, and Sjögren' s-related reac tive pleomorphic Iymph oid-epitheliallesion. In three patients, cyto logy was suggestive of, but not defi nitive for, a specific diag nosis; cyto logy sugges ted an adeno ma in one parotid mass, and it showed rare atyp ical ee lis in two patients with melano ma who had otherwise beni gn Iymph oid ee lis. In the rema inin g two patients, cytology was nondi agnostic. There were no complications related to any of the biopsies.
Excisional surgical biop sy was performed on six patients with definit ive or suggestive cytolo gy, and histology agreed with cytology in five: one case each of adenoid-cys tic carcinoma, Warth in ' s tumor, parotid lymphoma , benign lymph node, and reactive lymph node . In the sixth patient , cytology of a parotid mass was con sistent with an adenoma, but excisional biop sy later revealed that it was an acinic cell carcinom a.
Excision al biop sy was also performed on two patient s with parotid masses whose cytology was nondiagno stic (benign acinar cells). At surgery , one mass was proven to be a pleomorphic adenoma, and the other was proven to be a cavern ous hemangioma. One other pati ent whose cytology was definitive for a pleomorphic adenoma was recommended for surgery, but the pati ent refused.
Clinical OI' imaging follow up was available in the nine cases in which excisional biopsy was not performed, and the clinical course was compatible with the cytologic diagnosis in all nine .
A subse t of five patients had melanoma. Cytolo gy revealed metastatic melanoma in two, and atypical OI' ben ign Iymphoc ytes in the other three ; of the latter thre e, surge ry confirmed a benign Iymph node in one, and clin ical followup was comp atible with benign disease in the other two, Statistical analysis of the data show ed that FNAB was abIe to establish a definitive tissue diagno sis, benign OI' mali gnant, with 83% accuracy .
Discussion
Prima ry salivary gland tumors are relati vely rare, occurring in between I and 2 per 100 ,000 populati on ; they repre sent less than 3% of all head and neck tumors.P" Intraglandul ar metastases to the parotid gland are less common than primary neoplasms because most metastases of the aerodigestive tract spread via the deep cervical OI' interna i ju gul ar chain." The managem ent of both beni gn and mal ignant salivary gland masses requires surgical excision. Surgery is more extensive for high-grade tum ors and for tumo rs with local extension and regional Iymphadenopathy.": " In the case ofly mph nodes, their detection in the head and neck region can be a sign of neopla sms at the base of the tongue, pharynx, OI' larynx, particularly in patient s who have a history of cigarette smoking.
Because many head and neck abnormalities seen on MRI and CT are not palpable, sonog raphically guided biopsy of salivary gland masses is log ical. Sonographic guidance is critical to assuring that the mass being biop sied correlates with other imaging findings . Son ographically guided biopsy allows for the confident identification of the needIe tip within the mass. Even when submandibular and parotid masses are palpable, it might not be possible to clinically distingui sh an enlarged region allymph node from a true sali vary gland ma ss.
Imaging-guided FNAB has proven to be useful in a variety of head and neck applications, particularly in cases of metastatic Iymph node s and thyroid nodules .":" Acco rding to the literature , the se ns it iv ity o f sonographically guided FNAB of head and neck Iymph node met astases ranges from 76 to 98%, and its spec ificity ranges from 93 to 100%.1 2. 1 6.17.20 A recent pro spective series concluded that the distinction between malignant and benign Iymph node s based on real-time sono graph y is unreliable; these authors reported a se nsitivity of77 % and a specific ity of 100% for sonographically guided FNAB .20 Mo st parotid masses are hypoecho ic but , again , their echotexture alon e cannot be relied on for a specific histologic diagnosis. Usin g the cr iterion of sha rp 01' illdefined bo rders to distingui sh benign from mali gnant ma sses, one series found that 28 % of malignant parotid tumors (including meta stases and Iymph om as) had benign sonographic feature s." These authors also felt that in the ju gulodigastric region, it can be difficult, even with sonography, to det ermine the exact origin of a mass because sonography cannot demonstrat e the entire salivary gland capsule. Because our institution is a referral center for melanoma, a large proportion of our patients (5/ 18 [28 %]) had this disease. Met asta ses from melanoma to the parotid gland usually occur when the melanoma is located in the temporaI skin. The cytologic dia gno sis is extremely helpful in this subset of patients bec ause a positive dia gno sis will be treated med ically and a benign aspira te will be followed clinically. In either case, surgieal biopsy is usually not nece ssary .
The ea rly literature on cytology reported that the cytologic evalu ation of aspirated mater ial from sal ivary gland tumors wa s mo st challeng ing because of the wid e variety of tumor type s and the heterogeneity of cell popul ation s in individual turno rs.' How ever, as cytol ogic experi ence has grown , the accuracy of cytologic diagno ses has increased and now ranges from 60 to 98 %.7The limitations of FNAB are relat ed primarily to sampling errors. The surgeon can never be certain whether a rep ort of benign cytology is in fact the result of the benign nature of the mass or a failure to sample its most mali gnant component.
In one case in our ser ies, cy tology was misle ading in a parotid mas s that was read as an adenoma but which proved to be an acinic cell carcinoma at surge ry . After the cytologic mate rial in this case was reanalyzed, we felt , even in retrospect, that it showed sca nty cellularity and was compatible with adenoma. We consider this to be a false-negative result cau sed by a sampling error. Regardless, the man agement of this case was the same: surgical excision. One pos sible approac h to reducing the number of fal se negatives might be to obt ain core biop sie s.
In our series, sonographically guided FNAB estab-Volume 78, Number 12 lished e ither a defin itive 0 1' sugges tive eliagnosis in 16 of 18 masses (89%) . Alth ough this ab solute rate is similar to tho se seen in larger clin ical se ries. ? we pro bably biop sied smaller masses. We cann ot be ce rtain of this. however. bec ause lesional measurements we re not reporteel in earlier clinical series based on palpati on.
The cases of two pat ient s with clinical presentation s of Sjögren ' s syndrome were interesting. Cytology in one patient who had bilat eral parotiel masses revealeel a lymphoma . Cytol ogy of the other revea leelreactive pleomorphic Iymphoiel and epithe lial cell s, a co mmon findi ng in this disease, and excluded Iymphom a.
An important limitation of our study is the sma ll number of patients. Bec ause saliva ry gland tumors are not common, the ex perience of any sing le instituti on will be limit ed. Another limit ation is that because our study was retros pective, fine-needle and core biop sy techniques we re not standardized.
From a practical standpoint, a definiti ve FNAB cyt ology gives the otolaryngologist important inform ation , which can be helpful in surgica l planning. Beginning with the premi se that all intraparotid lesion s must be surgic ally
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For In-service and Board Exams remove d, a defin itive FNAB could be used to plan more complete surgery, possibly even including the facial (VIIth) ner ve, It should be noted, however, that some surgeo ns will wait until perm anent sections of the excised tumor are definit e before they sa crifice the cr ani al nerve. If son ography shows intra-or perisaliv ary Iymph node s that are benign on FNAB cytology, clo se clinical foll owup seems to be acceptable, but onl y when the beni gn res ult concurs with the clini cal history, ph ysic al examin ation , and other appropriate studies . There rem ain s a subse t of masses, such as pleomorph ic aden om as and hernangiomas, that will be indeterminate on FNAB . Th ere fore , an imp ort ant precept of mana gement is that when cytologic findings do not agre e with the clinical impression , exc isional biop sy is warra nted. Sonographically guided biop sy has three advantag es over FNAB that is not guided by imag ing : 1) it allo ws for confident biop sy of ma sses see n on other cro ss-sectional im aging studies, 2) it is usually able to distin gui sh peri salivary Iymph nodes from true int rasali vary gland masses, and 3) it avo ids the pitfall of nondiagno stic aspiration of the cys tic component of masses. In conclusion, not all palp able abnor malities in the region of the saliva ry glands represent prirn ary salivary neoplasms, and FNAB ca n help distin gui sh Iymph node s fro m primary tumors. Sonographically guided FN AB cytology ca n help the otolary ngologis t in making management decisions. It allows for less radical surg ery for low-grade tum ors, and it avo ids surg ery for metast atic disease from kno wn primaries, such as melanoma.
